Omega-3 & Alzheimer’s Disease

A recent study published in the Journal of Neuroscience looked at the potential benefits omega-3 may have on Alzheimer’s Disease. Researchers found that a reduction in a specific protein, SorLA (LR11) has been found in late-onset Alzheimer’s disease (LOAD) but not early-onset AD.

This new study observed that DHA, an essential omega-3 fatty acid, significantly increases LR11 in multiple systems including the brain. Therefore, if taking Omega-3 can increase SorLA/LR11 levels, it may help prevent late-onset Alzheimer’s disease (LOAD).*

Viteyes® Omega-3 contains 1,000mg of omega-3 fatty acids, 300 mg of EPA and 200mg of DHA in one convenient softgel per day.

*Qiu-Lan Ma, B. Teter, O.J. Ubeda, T. Morihara, D. Dhoot, M.D. Nyby, M.L. Tuck, S.A. Frautschy, G.M. Cole. “Omega-3 Fatty Acid Docosahexaenoic Acid Increases SorLA/LR11, a Sorting Protein with Reduced Expression in Sporadic Alzheimer’s Disease (AD): Relevance to AD Prevention” Journal of Neuroscience. December 2007, Volume 27, Pages 14299-14307; doi:10.1523/JNEUROSCI.3593-07.2007.

Comments are closed.